That database should improve detection of suspected adverse events and should allow and facilitate the pharmacovigilance surveillance and work-sharing between the competent authorities.
Ba cheart teagmhais dhíobhálacha amhrasta a bhrath ar bhealach níos fearr leis an mbunachar sonraí sin agus ba cheart a chur ar chumas na n-údarás inniúil faireachas cógas agus comhroinnt oibre a dhéanamh leis, agus an méid sin a éascú freisin.